Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Glutamate Receptor Ionotropic NMDA 2B Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 JNJ-0808
      • 1.3.3 Neu-2000
      • 1.3.4 NP-10679
      • 1.3.5 NP-11948
      • 1.3.6 Radiprodil
      • 1.3.7 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Share by Application (2019-2025)
      • 1.4.2 Acute Ischemic Stroke
      • 1.4.3 Autism
      • 1.4.4 Brasin Ischemia
      • 1.4.5 Burns
      • 1.4.6 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size
      • 2.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue 2014-2025
      • 2.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales 2014-2025
    • 2.2 Glutamate Receptor Ionotropic NMDA 2B Growth Rate by Regions
      • 2.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Regions 2014-2019
      • 2.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Glutamate Receptor Ionotropic NMDA 2B Sales by Manufacturers
      • 3.1.1 Glutamate Receptor Ionotropic NMDA 2B Sales by Manufacturers 2014-2019
      • 3.1.2 Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturers (2014-2019)
      • 3.2.2 Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Concentration Ratio (CR5 and HHI)
    • 3.3 Glutamate Receptor Ionotropic NMDA 2B Price by Manufacturers
    • 3.4 Key Manufacturers Glutamate Receptor Ionotropic NMDA 2B Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Glutamate Receptor Ionotropic NMDA 2B Market
    • 3.6 Key Manufacturers Glutamate Receptor Ionotropic NMDA 2B Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 JNJ-0808 Sales and Revenue (2014-2019)
      • 4.1.2 Neu-2000 Sales and Revenue (2014-2019)
      • 4.1.3 NP-10679 Sales and Revenue (2014-2019)
      • 4.1.4 NP-11948 Sales and Revenue (2014-2019)
      • 4.1.5 Radiprodil Sales and Revenue (2014-2019)
      • 4.1.6 Others Sales and Revenue (2014-2019)
    • 4.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type
    • 4.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type
    • 4.4 Glutamate Receptor Ionotropic NMDA 2B Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application

    6 United States

    • 6.1 United States Glutamate Receptor Ionotropic NMDA 2B Breakdown Data by Company
    • 6.2 United States Glutamate Receptor Ionotropic NMDA 2B Breakdown Data by Type
    • 6.3 United States Glutamate Receptor Ionotropic NMDA 2B Breakdown Data by Application

    7 European Union

    • 7.1 European Union Glutamate Receptor Ionotropic NMDA 2B Breakdown Data by Company
    • 7.2 European Union Glutamate Receptor Ionotropic NMDA 2B Breakdown Data by Type
    • 7.3 European Union Glutamate Receptor Ionotropic NMDA 2B Breakdown Data by Application

    8 China

    • 8.1 China Glutamate Receptor Ionotropic NMDA 2B Breakdown Data by Company
    • 8.2 China Glutamate Receptor Ionotropic NMDA 2B Breakdown Data by Type
    • 8.3 China Glutamate Receptor Ionotropic NMDA 2B Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Glutamate Receptor Ionotropic NMDA 2B Breakdown Data by Company
    • 9.2 Rest of World Glutamate Receptor Ionotropic NMDA 2B Breakdown Data by Type
    • 9.3 Rest of World Glutamate Receptor Ionotropic NMDA 2B Breakdown Data by Application
    • 9.4 Rest of World Glutamate Receptor Ionotropic NMDA 2B Breakdown Data by Countries
      • 9.4.1 Rest of World Glutamate Receptor Ionotropic NMDA 2B Sales by Countries
      • 9.4.2 Rest of World Glutamate Receptor Ionotropic NMDA 2B Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 BioCrea GmbH
      • 10.1.1 BioCrea GmbH Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Glutamate Receptor Ionotropic NMDA 2B
      • 10.1.4 Glutamate Receptor Ionotropic NMDA 2B Product Introduction
      • 10.1.5 BioCrea GmbH Recent Development
    • 10.2 Bristol-Myers Squibb Company
      • 10.2.1 Bristol-Myers Squibb Company Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Glutamate Receptor Ionotropic NMDA 2B
      • 10.2.4 Glutamate Receptor Ionotropic NMDA 2B Product Introduction
      • 10.2.5 Bristol-Myers Squibb Company Recent Development
    • 10.3 Cerecor Inc.
      • 10.3.1 Cerecor Inc. Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Glutamate Receptor Ionotropic NMDA 2B
      • 10.3.4 Glutamate Receptor Ionotropic NMDA 2B Product Introduction
      • 10.3.5 Cerecor Inc. Recent Development
    • 10.4 Johnson & Johnson
      • 10.4.1 Johnson & Johnson Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Glutamate Receptor Ionotropic NMDA 2B
      • 10.4.4 Glutamate Receptor Ionotropic NMDA 2B Product Introduction
      • 10.4.5 Johnson & Johnson Recent Development
    • 10.5 Luc Therapeutics, Inc.
      • 10.5.1 Luc Therapeutics, Inc. Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Glutamate Receptor Ionotropic NMDA 2B
      • 10.5.4 Glutamate Receptor Ionotropic NMDA 2B Product Introduction
      • 10.5.5 Luc Therapeutics, Inc. Recent Development
    • 10.6 NeurOp, Inc
      • 10.6.1 NeurOp, Inc Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Glutamate Receptor Ionotropic NMDA 2B
      • 10.6.4 Glutamate Receptor Ionotropic NMDA 2B Product Introduction
      • 10.6.5 NeurOp, Inc Recent Development
    • 10.7 Novartis AG
      • 10.7.1 Novartis AG Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Glutamate Receptor Ionotropic NMDA 2B
      • 10.7.4 Glutamate Receptor Ionotropic NMDA 2B Product Introduction
      • 10.7.5 Novartis AG Recent Development
    • 10.8 UCB S.A.
      • 10.8.1 UCB S.A. Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Glutamate Receptor Ionotropic NMDA 2B
      • 10.8.4 Glutamate Receptor Ionotropic NMDA 2B Product Introduction
      • 10.8.5 UCB S.A. Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Glutamate Receptor Ionotropic NMDA 2B Sales Channels
      • 11.2.2 Glutamate Receptor Ionotropic NMDA 2B Distributors
    • 11.3 Glutamate Receptor Ionotropic NMDA 2B Customers

    12 Market Forecast

    • 12.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales and Revenue Forecast 2019-2025
    • 12.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Type
    • 12.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Application
    • 12.4 Glutamate Receptor Ionotropic NMDA 2B Forecast by Regions
      • 12.4.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Glutamate Receptor Ionotropic NMDA 2B is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Glutamate Receptor Ionotropic NMDA 2B.

      This report studies the global market size of Glutamate Receptor Ionotropic NMDA 2B, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Glutamate Receptor Ionotropic NMDA 2B sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      BioCrea GmbH
      Bristol-Myers Squibb Company
      Cerecor Inc.
      Johnson & Johnson
      Luc Therapeutics, Inc.
      NeurOp, Inc
      Novartis AG
      UCB S.A.

      Market Segment by Product Type
      JNJ-0808
      Neu-2000
      NP-10679
      NP-11948
      Radiprodil
      Others

      Market Segment by Application
      Acute Ischemic Stroke
      Autism
      Brasin Ischemia
      Burns
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Glutamate Receptor Ionotropic NMDA 2B status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Glutamate Receptor Ionotropic NMDA 2B manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Glutamate Receptor Ionotropic NMDA 2B are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now